Posted: July 2, 2011 at 8:20 am
http://www.youtube.com stem cells plastic surgery or stem cells cosmetic surgery is the latest and one of the healthier and safer options in the field of Aesthetic Regeneration With Stem Cells to help you love your body naturally, stem cells cosmetic surgery: New in 2011 Naturally enhance your...
Read more:
Stem Cells Plastic Surgery 813-884-0160 Aesthetic Regeneration With Stem Cells
Posted: July 1, 2011 at 11:54 am
Central Animal Hospital of St Petersburg, FL now offers in house stem cell therapy for osteoarthritis for dogs!
Read more from the original source:
Stem Cell therapy at Central Animal Hospital St Petersburg Florida
Posted: July 1, 2011 at 12:01 am
(Part 3 of 7) Neal Hermanowicz, specialist, and, gave the keynote presentation at "Synapses Firing: Connections Made", a patient advocacy event hosted by the California stem cell funding agency (CIRM).
See the original post:
Alzheimer's Stem Cell Research Patient Advocate Spotlight: The Faces of Neurodegenerative Disease
Posted: June 30, 2011 at 5:11 am
Dr David Hille of Park Cities Animal clinic performs the first stem cell procedure in Dallas, TX that is done from beginning to end entirely in veterinary clinic. http://www.parkcitiesanimalhospital.com For more information about stem cell regenerative therapy visit: http://www.medivet-southtexas.com
View original post here:
Stem cells help Dallas Dog
Posted: June 30, 2011 at 5:11 am
See the rest here:
Man Cured Of HIV By Stem Cell Treatment
Posted: June 29, 2011 at 9:29 pm
(Part 2 of 3) Gary Steinberg, MD, Ph.D., spoke at the "Spotlight on Disease Team Awards: Sub-Cortical Stroke," an educational event presented at the CIRM Governing Board meeting on August 19, 2010. Steinberg is the principle investigator for the CIRM Stroke Disease Team. He is also the director of the Stanford Institute for Neuro-Innovation
See the original post:
Stem Cell Therapy for Stroke - Gary Steinberg, Stanford University
Posted: June 29, 2011 at 4:28 am
This story documents Ryan Benton's most recent trip from his home in Wichita, Kansas to the Stem Cell Institute in Panama City, Panama to receive stem cell therapy for muscular dystrophy. Follow Ryan as he lands at Tocumen International airport, receives treatment and returns home.
See the article here:
Documentary: Stem Cell Therapy for Muscular Dystrophy - Ryan Benton's Story
Posted: June 29, 2011 at 4:27 am
On June 15, 2010, the International Society for Stem Cell Research (ISSCR) in partnership with CIRM presented a public forum on the responsible path for delivering stem cell therapies to the clinic. The forum was moderated by Rachel Myrow, a host and reporter at KQED radio
Link:
A Dose of Reality on Alternative Stem Cell Treatments: What you don't know can hurt you
Posted: June 26, 2011 at 4:07 pm
(HealthDay News) -- Heart damage caused by heavy cocaine use can occur without producing any symptoms, according to a new study.
Researchers assessed the heart health of 30 long-term cocaine users, average age 37, who entered a drug rehabilitation program 48 hours after they last used cocaine. They had been using cocaine for an average of 12 years and consumed about 5.5 grams of cocaine per day.
Snorting was the most common way of using cocaine, but 10 said they injected intravenously and two said they smoked it (crack cocaine).
More than half of the those addicted to cocaine also used other substances -- such as heroin and alcohol -- and one in five was infected with either hepatitis C or HIV.
Heart function was normal in all the daily cocaine users, but 12 had localized abnormalities, 83 percent had structural damage, and 47 percent had swelling (edema) in the lower left ventricle. Edema was associated with greater cocaine consumption. Read more...
Cardiofy Heart Care Supplement
Posted: June 26, 2011 at 4:07 pm
Andrey Semechkin, Ph.D., CEO of International Stem Cell Corporation (OTCBB:ISCOE) ("ISCO") announced today that Kurt May, a highly experienced senior business executive and biotechnology entrepreneur, is concluding his service as a faculty member at the University of San Diego's School of Business Administration and is joining ISCO as a Senior Vice President.
Mr. May's duties will include mergers and acquisitions and development of new international collaborations, and he will work directly with Dr. Semechkin in implementing the Company's business model of combining cutting-edge scientific research and building multiple revenue streams to support that research.
Prior to joining ISCO, Mr. May was a senior executive with GTE Corporation, a Fortune 50 company, where he enjoyed 23 years of progressive management experience. Mr. May then went on to serve as Executive Vice President and Chief Operating Officer with PriceSmart Inc. Since 2001 Mr. May has founded and led a privately owned biotech company, Psynomics Inc., as CEO. Psynomics Inc. is a spin out of the University of California San Diego, where Mr. May served as a faculty member and Assistant Dean of the Rady School of Management from 2005 until 2009.
"Mr. May strengthens an accomplished management team at ISCO, and I am delighted that we attracted a professional of his caliber to our Company," said ISCO'S CEO, Dr. Semechkin.
About International Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells with minimal immune rejection after transplantation into hundreds of millions of individuals of differing genders, ages and racial background. This offers the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, and cell-based skin care products through its subsidiary Lifeline Skin Care. More information is available at http://www.internationalstemcell.com.
To subscribe to receive ongoing corporate communications, please click on the following link:http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0.
Forward-looking Statements
Statements pertaining to anticipated developments, and other opportunities for the company and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact (including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "estimates,") should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, risks inherent in the development and/or commercialization of potential products, competition, regulatory approvals, need and ability to obtain future capital, application of capital resources among competing uses, and maintenance of intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the company's business, particularly those mentioned in the cautionary statements found in the company's Securities and Exchange Commission filings. The company disclaims any intent or obligation to update forward-looking statements.
International Stem Cell Corporation
Andrey Semechkin, PhD
CEO & President
760-940-6383
aes@intlstemcell.com
or:
Lippert/Heilshorn & Associates
Don Markley, 310-691-7100
dmarkley@lhai.com
